Annual Accounts Payable
$37.52 M
+$174.00 K+0.47%
31 December 2023
Summary:
Apellis Pharmaceuticals annual accounts payable is currently $37.52 million, with the most recent change of +$174.00 thousand (+0.47%) on 31 December 2023. During the last 3 years, it has risen by +$29.04 million (+342.56%). APLS annual accounts payable is now at all-time high.APLS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$42.73 M
+$4.46 M+11.65%
30 September 2024
Summary:
Apellis Pharmaceuticals quarterly accounts payable is currently $42.73 million, with the most recent change of +$4.46 million (+11.65%) on 30 September 2024. Over the past year, it has increased by +$24.54 million (+134.88%). APLS quarterly accounts payable is now at all-time high.APLS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APLS Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.5% | +134.9% |
| 3 y3 years | +342.6% | +757.3% |
| 5 y5 years | +265.8% | +261.0% |
APLS Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +342.6% | at high | +757.3% |
| 5 y | 5 years | at high | +348.7% | at high | +1288.2% |
| alltime | all time | at high | >+9999.0% | at high | +5586.0% |
Apellis Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $42.73 M(+11.7%) |
| June 2024 | - | $38.27 M(+42.9%) |
| Mar 2024 | - | $26.79 M(-28.6%) |
| Dec 2023 | $37.52 M(+0.5%) | $37.52 M(+106.2%) |
| Sept 2023 | - | $18.19 M(-33.8%) |
| June 2023 | - | $27.50 M(-12.7%) |
| Mar 2023 | - | $31.49 M(-15.7%) |
| Dec 2022 | $37.34 M(+120.8%) | $37.34 M(+164.9%) |
| Sept 2022 | - | $14.10 M(-13.1%) |
| June 2022 | - | $16.22 M(+32.2%) |
| Mar 2022 | - | $12.27 M(-27.4%) |
| Dec 2021 | $16.91 M(+99.5%) | $16.91 M(+239.3%) |
| Sept 2021 | - | $4.98 M(-6.6%) |
| June 2021 | - | $5.34 M(+28.4%) |
| Mar 2021 | - | $4.16 M(-50.9%) |
| Dec 2020 | $8.48 M | $8.48 M(-23.4%) |
| Sept 2020 | - | $11.07 M(+11.5%) |
| June 2020 | - | $9.93 M(+222.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $3.08 M(-63.2%) |
| Dec 2019 | $8.36 M(-18.5%) | $8.36 M(-29.4%) |
| Sept 2019 | - | $11.84 M(-14.3%) |
| June 2019 | - | $13.81 M(+15.9%) |
| Mar 2019 | - | $11.92 M(+16.2%) |
| Dec 2018 | $10.25 M(+179.9%) | $10.25 M(+87.5%) |
| Sept 2018 | - | $5.47 M(+6.5%) |
| June 2018 | - | $5.13 M(+11.9%) |
| Mar 2018 | - | $4.59 M(+25.2%) |
| Dec 2017 | $3.66 M(+43.8%) | $3.66 M(-8.4%) |
| Sept 2017 | - | $4.00 M(+53.6%) |
| June 2017 | - | $2.60 M(+2.2%) |
| Dec 2016 | $2.55 M(+2.8%) | $2.55 M(+2.8%) |
| Dec 2015 | $2.48 M(+229.7%) | $2.48 M(+95.4%) |
| Sept 2015 | - | $1.27 M(+52.7%) |
| June 2015 | - | $830.20 K(+10.5%) |
| Dec 2014 | $751.50 K(+112.3%) | $751.50 K |
| Dec 2013 | $353.90 K | - |
FAQ
- What is Apellis Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual accounts payable year-on-year change?
- What is Apellis Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly accounts payable year-on-year change?
What is Apellis Pharmaceuticals annual accounts payable?
The current annual accounts payable of APLS is $37.52 M
What is the all time high annual accounts payable for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual accounts payable is $37.52 M
What is Apellis Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, APLS annual accounts payable has changed by +$174.00 K (+0.47%)
What is Apellis Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of APLS is $42.73 M
What is the all time high quarterly accounts payable for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly accounts payable is $42.73 M
What is Apellis Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, APLS quarterly accounts payable has changed by +$24.54 M (+134.88%)